Why Tesamorelin Prices Vary Between Vendors
A breakdown of why tesamorelin prices vary between vendors, covering vial size, concentration, purity testing, and how listings quote per-mg cost.
Reviewed by Robert Stern, PharmD, RPh, pharmacist and pharmaceutical researcher ·
Robert Stern, PharmD, RPh is a registered pharmacist with a research background in peptide hormones and GHRH analog formulation, with experience spanning hospital pharmacy and pharmaceutical research environments.
- tesamorelin
- pricing
- cost
A single search for tesamorelin turns up listings that differ by a wide margin for what looks like the same product. Understanding why tesamorelin prices vary between vendors starts with recognizing that a vial price alone tells you very little — vial size, concentration once reconstituted, purity documentation, and how a supplier bundles ancillary items all factor into the number on the page. Two listings quoting different totals may not be describing comparable products at all.
Vial Size Is the First Variable
Tesamorelin is typically listed in specific milligram amounts per vial, and the milligram count is the baseline unit for comparison — not the sticker price. A vial priced lower than another may simply contain less peptide. Before comparing two listings, the milligram content per vial needs to be lined up side by side, because a lower total price on a smaller vial can still work out to a higher cost per milligram than a pricier vial with more content.
This is the single most common reason two tesamorelin listings appear mismatched at first glance. A buyer scanning only the sticker price without checking the mg-per-vial figure is comparing two different units, not two different prices for the same thing.
Per-Milligram Cost Is the Real Comparison Point
Once vial size is accounted for, the number that actually allows an apples-to-apples comparison is cost per milligram: total price divided by the milligram amount in the vial. This is the figure that should anchor any table comparing vendors, because it strips out the vial-size variable entirely.
| Vial size | Listed price | Cost per mg |
|---|---|---|
| 5 mg | $70 | $14.00 |
| 10 mg | $120 | $12.00 |
| 20 mg | $210 | $10.50 |
The arithmetic behind that table is simple division — price divided by milligrams — but it is worth working through once so the pattern is clear. Take the 10 mg row: $120 divided by 10 mg equals $12.00 per mg. Checking it a second way, 10 mg at $12.00 per mg comes back to $120, which matches the listed price, confirming the figure. The same check on the 20 mg row: $210 divided by 20 mg is $10.50 per mg, and $10.50 times 20 mg returns $210. Larger vials frequently carry a lower per-mg figure, which is a packaging and handling economy rather than a difference in the compound itself.
Concentration After Reconstitution Is a Separate Number From Price
Cost per milligram describes what a vial costs before anything is added to it. Concentration is a separate calculation that only matters once bacteriostatic water has been added, and it does not change what the vial cost — it changes how that milligram amount is distributed across a liquid volume. Concentration is calculated as the milligram amount in the vial divided by the milliliters of bacteriostatic water used to reconstitute it.
As an example, a 10 mg vial reconstituted with 2 mL of bacteriostatic water works out to 10 mg ÷ 2 mL = 5 mg/mL. On a U-100 insulin syringe, where 1 mL corresponds to 100 unit markings, that 5 mg/mL concentration means each 10-unit mark on the syringe corresponds to 0.1 mL, or 0.5 mg. Recomputing to confirm: 100 units is 1 mL at 5 mg/mL, so 100 units holds 5 mg total; 10 units is one-tenth of that volume, or 0.5 mg. Both passes agree. This kind of figure explains why a listing might mention “5 mg/mL” alongside the price — it is describing the reconstituted solution, not the vial cost, and conflating the two is a frequent source of confusion when comparing vendors.
Purity Documentation and Testing Add to Overhead
Listings that include a certificate of analysis or third-party purity testing tend to carry a higher price than listings that don’t mention any testing at all. That difference reflects the cost of the testing process itself, not necessarily a difference in the underlying compound. A listing with no visible documentation isn’t automatically lower quality, but it also gives a buyer no independent figure to check the vendor’s own claims against, which is part of why documented listings often price higher.
Bundling, Shipping, and Minimum Order Size
Some vendors quote a lower per-vial price but require a multi-vial minimum order, which changes the effective cost when shipping and handling are added in. Others bundle bacteriostatic water, syringes, or alcohol swabs into the listed price, which raises the sticker number but removes a separate purchase. Reading what is actually included in a quoted price — not just the headline number — is necessary before any cross-vendor comparison holds up.
Revision Dates Matter More Than They Seem
Peptide pricing shifts with sourcing costs and supply availability, so a listing’s revision date is part of what makes a price comparison meaningful. A table compiled weeks apart from another can reflect different market conditions entirely, which is one more reason why tesamorelin prices vary between vendors even when nothing about the compound itself has changed. Tables that carry a visible last-updated date are more useful for comparison than ones that don’t specify when the figures were pulled.
For readers comparing figures across sources, cross-referencing a broader catalogue of peptide listings — such as heezresearch.com/ — can help establish whether a given quote sits near the middle of the market or well outside it. This kind of network view is useful precisely because single-vendor prices tell you very little in isolation.
Community-compiled trackers and forums, including resources across peer tesamorelin listing catalogs, often archive older listings, which is useful for spotting whether a given price has drifted up or down over time rather than relying on a single snapshot.
Reading a Listing Correctly
Putting these pieces together, a tesamorelin listing should be read in this order: milligram content per vial, price divided by that milligram figure, any documentation backing the stated purity, what is bundled into the price, and when the figure was last revised. Skipping straight to the sticker price and comparing it across vendors is the most common way to draw the wrong conclusion about which listing is actually the better value.
Summary
Vendor-to-vendor price differences for tesamorelin come down to a handful of concrete variables rather than arbitrary markup: vial size, the resulting cost per milligram, documented purity testing, what’s bundled into the order, and how recently the listing was revised. Working through those factors in order, rather than comparing sticker prices directly, is what makes a comparison between listings actually meaningful.